chrisvoncsefalvay/vaers-outcomes huggingface dataset:
no adverse effects reported; patient was vaccinated with improperly stored MMR II; This spontaneous report has been received from a medical assistant, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not provided.  On 01-JAN-2019, the patient was vaccinated with improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (albumin status rHA) one dose, lot # N023024 with expiration date 23-AUG-2019 (frequency, route and anatomical location were not provided) which was reconstituted with sterile diluent (dose, frequency, route, lot number and expiration date were not provided) for prophylaxis. No adverse effects reported.  The temperature and time frame were unknown by reporter. There was previously temperature excursions and digital data logger was involved.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1906USA011469: US-009507513-1907USA010301: US-009507513-1907USA010302: US-009507513-1907USA010303: US-009507513-1907USA010304: US-009507513-1907USA010305: US-009507513-1907USA010306: US-009507513-1907USA010307: US-009507513-1907USA010309: US-009507513-1907USA010310: US-009507513-1907USA010311: US-009507513-1907USA010312: US-009507513-1907USA010313: US-009507513-1907USA010314: US-009507513-1907USA010315: US-009507513-1907USA010316: US-009507513-1907USA010317: US-009507513-1907USA010318: US-009507513-1907USA010319: US-009507513-1907USA010320: US-009507513-1907USA010321: US-009507513-1907USA010322: US-009507513-1907USA010323: US-009507513-1907USA010324: US-009507513-1907USA010325: US-009507513-1907USA010326: US-009507513-1907USA010327: US-009507513-1907USA010328: US-009507513-1907USA010329: US-009507513-1907USA010330: US-009507513-1907USA010331: US-009507513-1907USA010332: US-009507513-1907USA010333: US-009507513-1907USA010334: US-009507513-1907USA010335: US-009507513-1907USA010336: US-009507513-1907USA010337: US-009507513-1907USA010338: US-009507513-1907USA010339: US-009507513-1907USA010340: US-009507513-1907USA010341: US-009507513-1907USA010342: US-009507513-1907USA010343: US-009507513-1907USA010344: US-009507513-1907USA010345: US-009507513-1907USA010346: US-009507513-1907USA010347: US-009507513-1907USA010348: US-009507513-1907USA010349: US-009507513-1907USA010350: US-009507513-1907USA010351: US-009507513-1907USA010352: US-009507513-1907USA010353: US-009507513-1907USA010354: US-009507513-1907USA010355: US-009507513-1907USA010356: US-009507513-1907USA010357: US-009507513-1907USA010358: US-009507513-1907USA010359: US-009507513-1907USA010360: US-009507513-1907USA010361: US-009507513-1907USA010362: US-009507513-1907USA010363: US-009507513-1907USA010364: US-009507513-1907USA010365: US-009507513-1907USA010366: US-009507513-1907USA010367: US-009507513-1907USA010368: US-009507513-1907USA010369: US-009507513-1907USA010370: US-009507513-1907USA010371: US-009507513-1907USA010372: US-009507513-1907USA010373:
12 year old child received PEDIATRIC  (Pfizer-BioNTech 5-11yr formulation) dose at 02/09/2022 Booster appointment instead of Adult  (Pfizer-BioNTech 12+ yr formulation) dose.
This spontaneous report as received from a pharmacist refers to multiple unspecified patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant medications were not provided. On an unknown date, the patients might have received unspecified doses of RECOMBIVAX HB injection (route of administration, lot# and expiration date were not reported) that were left out of the refrigerator for up to four hours prior to administration. No adverse effects were reported. Additional information has been requested.
Anaphylactic reaction, 24 hours post vax. Given cortisone, antihistamines and symptoms resolved, shortly thereafter. Perioral swelling, rash.
Dizzy spells, right after the shot and the next morning Nausea spells, intermittently for a couple days Alternating Flushing and Chilling, day after the shot Injection Site Warm to Touch, intermittently the day after  Muscle Aches, the day after the shot Fatigue, intermittently for a couple days
Mom phoned office in evening on 8/6/04 at 11:00PM c/o fever (as high as 103), redness, swelling in upper right arm of injection site.
I started having shortness of breath while walking. It has been gradually been increasing. I started getting edema in my stomach, legs, and feet.  I went to the doctor and they don't have a diagnosis yet, but they said that I am anemic. I was prescribed Lasix and an Advair inhaler, but it has not really helped yet.
fever; Chills; a very big Lymph Node on my left arm armpit; This is a spontaneous report from a contactable other hcp (patient). A 39-year-old female patient received their second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL3248, expiry date not reported), via an unspecified route of administration on the left arm on 10Jan2021 10:43 at single dose for COVID-19 immunization. Medical history was not reported. Concomitant medication included gabapentin. The patient previously received their first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EH9899, expiry date not reported) on the left arm on 24Dec2020 for COVID-19 immunization. The patient experienced fever, chills, and a very big lymph node on their left arm armpit on 11Jan2021 21:00. The outcome of the events was unknown.
increased heart rate, headache, pain in chest, nausea  took Advil, drank fluids, slept
Patient was given a pneumovax shot on Monday. On Tuesday, patient came in with redness/swelling. Patient was then instructed to monitor. Patient came back on wednesday with the swelling/redness spreading down to elbow. Patient was instructed to go the ER where she was given a 5 day course of antibiotics (Cephalexin).
After receiving flu vaccine about 5 hours started having swelling, warmth, itching, pain at site.
No additional AE; Medical assistant called to report that a patient was administered an expired dose of ROTATEQ. Caller stated the dose expired on 10/16/2023 and was administered on 11/15/2023.; This spontaneous report was received from medical assistant and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 15-NOV-2023, the patient was vaccinated with expired dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) 1 dose, administered orally, lot # 1879870, expiration date 16-OCT-2023 (exact dose for not reported) for prophylaxis. Reporter stated that vaccine was not involved in any temperature excursions. No additional adverse event was reported.
Initial unsolicited literature report received from healthcare professional on 18 June 2015. This case is linked to case ID's: 2015SA090249, 2015SA090258, 2015SA090259, 2015SA090257, 2015SA090261, 2015SA090262. (Same literature, reporter and event). Abstract: Background: In October 2012, the Committee recommended dose of Tdap during each pregnancy, irrespective of the woman's prior history of receiving Tdap. A retrospective cohort study to assess the safety of Tdap vaccination in pregnant women in two Vaccine Safety Datalink (VSD) sites during 2010-2012 found a small but statistically significant increased risk of chorioamnionitis. Objective: We conducted a review of the VAERS database to describe reports of chorioamnionitis following receipt of any vaccines. Methods: We searched the VAERS database for reports of chorioamnionitis after any vaccine during the period from July 1, 1990 through February 2, 2014. Results: VAERS received 31 reports of chorioamnionitis out of 3389 pregnancy reports in 24 years. The three most common vaccines in these reports were H1N1, quadrivalent human papillomavirus (HPV4), and Tdap vaccines in 32%, 29% and 26% of reports, respectively. Fifty-eight percent of reports had at least one reported risk factor for chorioamnionitis. Chorioamnionitis was identified in 3 reports of spontaneous abortions and 6 stillbirths, 6 reports of preterm birth (two of whom died) and 16 reports of term birth; maternal outcomes included two reports of postpartum hemorrhage and one report of maternal admission to the intensive care unit. No maternal deaths were reported. Conclusion: Chorioamnionitis was found to be uncommonly reported, representing 1% of pregnancy reports to VAERS. A majority of reports had at least one risk factor for chorioamnionitis. Two female patients, whose medical history and concomitant medications were not reported, had received a dose of Influenza vaccine and a dose of Tdap (batch number, route and site of administration were not reported for all vaccines) on unspecified date. On unspecified date after vaccinations, patients experienced chorioamnionitis and were pregnant during vaccination. The last menstrual period and estimated date of delivery was not reported. Pregnancy exposure timing was unknown. Laboratory investigations and corrective treatments were not reported. At the time of this report, outcome of the event was unknown. Upon medical review, the case was considered as serious due to important medical event: chorioamnionitis and vaccine exposure during pregnancy. Documents held by sender: none.
Within 5 days, experienced neck pain on right side. Headache for 2 days. Pain radiated to left side of neck. Felt a jerk while laying down in left leg and experienced numbness.  While blowing nose, experienced nose bleed. 2 days ago, stretched my arms and the right side of my neck locked. Nausea and drowsiness. Right arm has weakness. Also experienced itchiness on site where vaccine was administered.
The same day about 8pm my arm begin to itch.  I noticed I had a large red, warm knot on my arm.  The next day the swelling grew in diameter . To date its larger but no longer is it hot or raised any more but it is still red, visible and still itchy
Around 2 am the following day the side effects I was experiencing were fatigue and body/muscle aches (severe aches in my lower back and hips). This lasted the entire day until I went to bed around 10 o'clock. I had to use a heating pad for my back to reduce the pain.
Information has been received from a nurse for the Pregnancy Registry for HPV vaccine concerning a 23 year old female who on 18-APR-2008 was vaccinated with the first dose of GARDASIL vaccine (yeast) (lot#659182/1757U) IM. On 06-JUN-2008, was vaccinated with the second dose of GARDASIL vaccine (yeast) (lot#660389/1968U) IM. In September the patient was now pregnant. She had a positive pregnancy test. The patient's LMP was on 20-JUN-2008 and EDD 29-MAR-2009. No other symptoms were noted. Additional information has been requested.
no side effects; Medical assistant called to report an administered expired ROT ATEQ vaccine, vaccine expired 30-JAN-2021; This spontaneous report was received from a physician and a practice coordinator who worked at the providers office referring to a 6-month-old male patient. No information was provided regarding the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant medication.  On 10-FEB-2021, the patient was accidentally vaccinated with a single expired dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ), this was the third dose of the scheme, lot number S012931 and expiration date of 30-JAN-2021, orally for prophylaxis, the patient tolerated the inmmunization well. No side effects.   On the same date, the patient was vaccinated with  the third dose of: diphtheria toxoid, hepatitis b virus vaccine rhbsag (yeast), pertussis acellular 3-component vaccine, poliovirus vaccine inactivated (vero), tetanus toxoid(PEDIARIX) lot number AZ472 expiration date of 28-NOV-2022 intramuscularly at the right vastus lateralis, hib conj vaccine (tet toxoid)(HIBERIX) lot number TF4EB expiration date of 26-SEP-2021 intramuscularly at the right vastus lateralis, pneumococcal 4 6b 9v 14 18c 19f 23f conj vaccine (crm197)(PREVNAR) lot number DP5137 expiration date of 01-JAN-2023 intramuscularly at the left vastus lateralis and influenza virus split virion 3v vaccine inactivated(AFLURIA) lot number P100244052 expiration date of 30-JUN-2021.
1st Symptom- I felt a numbing and tingly sensation running down my arm as the vaccine was being injected, it traveled all the way down my arm and hand. 2nd Symptom-Same numbing sensation traveled up my arm, neck and left side of my face 3rd Symptom - My heart started to Flutter violently, felt it so strongly on my neck and these episodes have continued on an off since then.  4th Symptom- Sparkly floaters ( I believe they were related to abnormal heart beat)  5th Symptom- I fainted ( I believe it was related to the abnormal heart beat)  6th Symptom - My arm was puffy and hot to the touch for over 4 days after the vaccine
The injection did not enter my arm.  The fluid from the needle ran down my arm and onto the floor and my jeans.  None of the actual shot entered my body.  The technician ran and got paper towels and wiped up my arm and floor and advised that enough went into my system, that I would be fine.  When I realized how wet my pants were, I complained to the manager, who then called back to the pharmacy who advised him once again, I received enough. Now I am ineligible to actually be vaccinated due to the technician not telling the truth about what happened and the amount of the vaccine that did  not go into my body.
had not been feeling well since; could not eat; not being able to lift arm at all, not being able to move arm at all; random cramps in her left arm; could not sleep; chest pain stating that it felt like "heart burn"; shortness of breath; pain was excruciating; woke up with fever; headache with a pulsing feeling on her temples (both sides); aches in her left arm (can't lift her arm to put hair up), body aches; felt nauseous; given an expired second dose; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (given an expired second dose), MALAISE (had not been feeling well since), FEEDING DISORDER (could not eat), MOBILITY DECREASED (not being able to lift arm at all, not being able to move arm at all) and MUSCLE SPASMS (random cramps in her left arm) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included ORAL CONTRACEPTIVE NOS for Birth control.   On 29-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (given an expired second dose). On an unknown date, the patient experienced MALAISE (had not been feeling well since), FEEDING DISORDER (could not eat), MOBILITY DECREASED (not being able to lift arm at all, not being able to move arm at all), MUSCLE SPASMS (random cramps in her left arm), INSOMNIA (could not sleep), DYSPEPSIA (chest pain stating that it felt like "heart burn"), DYSPNOEA (shortness of breath), PAIN (pain was excruciating), PYREXIA (woke up with fever), HEADACHE (headache with a pulsing feeling on her temples (both sides)), MYALGIA (aches in her left arm (can't lift her arm to put hair up), body aches) and NAUSEA (felt nauseous). At the time of the report, EXPIRED PRODUCT ADMINISTERED (given an expired second dose), MALAISE (had not been feeling well since), FEEDING DISORDER (could not eat), MOBILITY DECREASED (not being able to lift arm at all, not being able to move arm at all), MUSCLE SPASMS (random cramps in her left arm), INSOMNIA (could not sleep), DYSPEPSIA (chest pain stating that it felt like "heart burn"), DYSPNOEA (shortness of breath), PAIN (pain was excruciating), PYREXIA (woke up with fever), HEADACHE (headache with a pulsing feeling on her temples (both sides)), MYALGIA (aches in her left arm (can't lift her arm to put hair up), body aches) and NAUSEA (felt nauseous) outcome was unknown.            No treatment information was reported.   This case was linked to MOD-2021-278676 (Patient Link).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: follow up recived on 04-AUG-2021 It contain no new information
pt recvd vax;c/o weakness 2-3 mins later;sat inc diaphoresis,pale,HR dec 36-38;BP 88-90; pt lost consciousness & had tonic clonic mvts time from LOC to responsiveness 90 secs;on floor & feet elev;returned to nl HR & BP limits w/in 3 mins;
In the middle of the night flu like symptoms began and lasted for approximately 24 hours and then severe  shooting pain in right testicle started.
Pain, redness, swelling, itching at site of injections. Patient with other complaints not feeling well, restless, poor appetite, fever.
I developed body aches approximately 9 hours after the vaccine.  I also had L arm pain.  About 12 hours after the vaccine I had worsening body ache, chills, and was febrile (T max 101.4F oral).  I continued to have fever, chills, and body aches for about 24 hours despite taking tylenol and motrin.  I also developed a localized skin reaction measuring about 6 inches in diameter on my Left upper arm but not at the injection site and also had two other small erythematous raised lesions near the injection site.
Pt was given the live, attenuated, intranasal vaccine and she is 16 weeks pregnant. 11/16/2009 OB-GYN records stating patient 16 weeks pregnant, received H1N1 on 11/12/2009, no adverse reactions noted at this time.
Fever, inflammation at site of vaccine. Pain at site. Course of AUGMENTIN given.
Pt experienced allergic reaction to Pertussis. Exhibited by persistent crying that started with immunization administration. Sent to ER.
VACCINE GIVEN TO 17 YEAR OLD PATIENT; This spontaneous report received from a pharmacist concerned an adolescent of unspecified sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020, and expiry: 25-MAY-2021) dose was not reported, administered on 27-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 27-MAR-2021, the vaccine given to 17 year old subject. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of vaccine given to 17 year old patient was not reported. This report was non-serious.
Left Biceps tendon partial rupture while weight lifting; This is a spontaneous report from a contactable physician (patient). A 47-year-old male patient received BNT162B2, via an unspecified route of administration, administered in left arm on 08Jan2021 (Batch/Lot Number: EL3248) at the age of 47 years old as dose 2, single for COVID-19 immunisation. Medical history included gastrooesophageal reflux disease (GERD) and psoriasis. No known allergies. There were no concomitant medications. No other vaccine in four weeks; no other medication in two weeks. No COVID prior vaccination; not COVID tested post vaccination. The patient previously received first dose of BNT162B2 (Batch/Lot Number: EJ1685) administered in right arm on 18Dec2021 at 11:30 AM. The patient experienced left biceps tendon partial rupture while weight lifting on 25Feb2021 11:00. Event resulted in Doctor or other healthcare professional office/clinic visit. Treatment received included surgery which was scheduled on 19Mar2021. Outcome of event was recovering.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on the currently available information  causal association between the event tendon rupture and the suspect drug BNT162B2 is considered unrelated.
Pressure headache swollen at the injection site bad joint pain swollen glands sore throat took 3 days for the pain  to go away
Systemic: Abdominal Pain-Mild, Systemic: Body Aches Generalized-Mild
autoimmune issues; Uncertain if patient has Covid 19 or if it is her autoimmune issues/whatever is going on with her daughter is affecting every system of her body.; Uncertain if patient has Covid 19 or if it is her autoimmune issues/whatever is going on with her daughter is affecting every system of her body.; This is a spontaneous report from a contactable consumer. This Consumer (patient's mother) reported for a female patient (reporter's daughter).  A female patient of an unspecified age received bnt162b2 (PFIZER BIONTECH COVID-19 MRNA VACCINE, Formulation: Solution for injection, Batch/lot number and Expiry Date: Not Provided), via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunisation. Medical history included celiac disease from an unknown date and unknown if ongoing. Concomitant medications were not reported. On an unspecified date, it was reported that it was uncertain if patient has Covid 19 currently or if it was her autoimmune issues. It was stated that her daughter had Covid 19 when the caller did and has had the Pfizer Vaccines, had never been tested for lupus and whatever was going on with her daughter was affecting every system of her body and she was uncertain if her daughter had Covid 19 or if it was her autoimmune symptoms causing issues. The clinical outcome of the events was unknown.  Information on Batch/lot number not available for [BNT162B2]; No further information is expected.
Not reported to us by parent until 5-20-04. Dad states patient's leg was swollen and bumpy around vaccine site 3-4 days after shot. Brought to clinic 5-20-04 and looked at by RN and doctor- raised 3 x3 inch area on right thigh with mottled look. Warm and painful to touch.